1KMX
Heparin-binding Domain from Vascular Endothelial Growth Factor
SOLUTION NMR
NMR Experiment | ||||||||
---|---|---|---|---|---|---|---|---|
Experiment | Type | Sample Contents | Solvent | Ionic Strength | pH | Pressure | Temperature (K) | Spectrometer |
1 | DQF-COSY | 2.0 mM VEGF heparin-binding domain; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
2 | 2D NOESY | 2.0 mM VEGF heparin-binding domain; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
3 | 3D_15N-separated_NOESY | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
4 | HNHA | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
5 | DQF-COSY | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 99.9% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
6 | 2D NOESY | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 99.9% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
7 | 2D 15N IPAP-HSQC | 2.0 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride, 0.02% sodium azide | 90% H2O/10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 | |
8 | 2D 15N IPAP HSQC | 0.6 mM VEGF heparin-binding domain U-15N; 25 mM sodium acetate; 50 mM sodium chloride; 0.02% sodium azide | 4:1:0.2 ditridecanoyl-phosphatidylcholine/dihexanoyl-phosphatidylcholine/cetyltrimethylammonium bromide, 5% w/v total lipid in 90% H2O, 10% D2O | 25 mM sodium acetate; 50 mM sodium chloride | 5.5 | ambient | 300 |
NMR Spectrometer Information | |||
---|---|---|---|
Spectrometer | Manufacturer | Model | Field Strength |
1 | Bruker | AMX | 500 |
2 | Bruker | DRX | 500 |
NMR Refinement | ||
---|---|---|
Method | Details | Software |
torsion angle dynamics | The structures are based on 459 NOE-derived distance restraints, 28 H-bond restraints, 66 dihedral angle restraints, and 38 residual dipolar coupling restraints | UXNMR |
NMR Ensemble Information | |
---|---|
Conformer Selection Criteria | structures with the least restraint violations |
Conformers Calculated Total Number | 100 |
Conformers Submitted Total Number | 20 |
Representative Model | 1 (fewest violations) |
Additional NMR Experimental Information | |
---|---|
Details | The structure was refined using 1H-15N dipolar coupling restraints |
Computation: NMR Software | ||||
---|---|---|---|---|
# | Classification | Version | Software Name | Author |
1 | collection | UXNMR | ||
2 | collection | XwinNMR | ||
3 | processing | Felix | ||
4 | data analysis | Felix | ||
5 | structure solution | CNX | ||
6 | refinement | CNX | Molecular Simulations, Inc. |